Suppr超能文献

体外大鼠肝脏溶酶体对丙咪嗪的摄取及其受碱性药物的抑制作用。

Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.

作者信息

Ishizaki J, Yokogawa K, Ichimura F, Ohkuma S

机构信息

Hospital Pharmacy, Kanazawa University, Japan.

出版信息

J Pharmacol Exp Ther. 2000 Sep;294(3):1088-98.

Abstract

We investigated the uptake of imipramine (IMP) in highly purified lysosomes from rat liver and its inhibition by a variety of basic drugs in vitro. The uptake of [(3)H]IMP into lysosomes peaked in less than 20 s, showing little temperature dependency or countertransport phenomena. It was accelerated by increase of extralysosomal pH, stimulated by Mg(2+)-ATP in KCl buffer, and suppressed by acidic ionophores. However, the uptake of [(3)H]IMP in lysosomes was approximately 140-fold higher than the value expected from the pH-partition theory. IMP and other weak lipophilic bases like chlorpromazine and propranolol raised the intralysosomal pH, and their potency was stronger than that of NH(4)Cl, a typical pH-perturbing weak base. A variety of basic drugs inhibited the uptakes of [(3)H]IMP and [(14)C]methylamine into lysosomes, their 50% inhibitory concentrations (IC(50)) being almost the same for [(3)H]IMP and [(14)C]methylamine uptake (r = 0.842). A high correlation (r = 0.946) was observed between the IC(50) values (for the inhibition of [(3)H]IMP uptake) and the lipophilicity (P(oct) values). These results suggest that the accumulation of lipophilic basic drugs is driven primarily by the transmembrane pH difference (pH-partition theory) but with the involvement of some additional mechanism(s) related to drug lipophilicity, possibly binding (partition or adsorption) to lipophilic substance(s) and/or aggregation within lysosomes. Based on this idea, we have established a model that described and successfully simulated the weak base-induced pH increase, the accumulation of a lipophilic weak base (IMP), and the inhibition of accumulation of IMP by lipophilic basic drugs.

摘要

我们研究了大鼠肝脏高度纯化溶酶体中丙咪嗪(IMP)的摄取及其在体外被多种碱性药物的抑制作用。[(3)H]IMP进入溶酶体的摄取在不到20秒内达到峰值,几乎没有温度依赖性或反向转运现象。其摄取通过溶酶体外pH的升高而加速,在KCl缓冲液中受Mg(2 +)-ATP刺激,并被酸性离子载体抑制。然而,[(3)H]IMP在溶酶体中的摄取比pH分配理论预期的值高约140倍。IMP和其他弱亲脂性碱如氯丙嗪和普萘洛尔提高了溶酶体内pH,且它们的效力比典型的pH扰动弱碱NH(4)Cl更强。多种碱性药物抑制[(3)H]IMP和[(14)C]甲胺进入溶酶体,它们对[(3)H]IMP和[(14)C]甲胺摄取的50%抑制浓度(IC(50))几乎相同(r = 0.842)。在IC(50)值(对[(3)H]IMP摄取的抑制)和亲脂性(辛醇分配系数值)之间观察到高度相关性(r = 0.946)。这些结果表明,亲脂性碱性药物的积累主要由跨膜pH差异驱动(pH分配理论),但涉及一些与药物亲脂性相关的额外机制,可能是与亲脂性物质的结合(分配或吸附)和/或在溶酶体内的聚集。基于这一观点,我们建立了一个模型,该模型描述并成功模拟了弱碱诱导的pH升高、亲脂性弱碱(IMP)的积累以及亲脂性碱性药物对IMP积累的抑制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验